Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China · Delayed Price · Currency is CNY 9.31
-0.14 (-1.48%)
Sep 10, 2026, 1:20 PM CST
SHE:002728 Revenue
Teyi Pharmaceutical Group Co.,Ltd had revenue of 183.45M CNY in the quarter ending June 30, 2026, a decrease of -6.41%. This brings the company's revenue in the last twelve months to 826.71M, down -4.45% year-over-year. In the year 2025, Teyi Pharmaceutical Group Co.,Ltd had annual revenue of 924.53M with 34.42% growth.
Revenue (ttm)
826.71M
Revenue Growth
-4.45%
P/S Ratio
5.84
Revenue / Employee
576.51K
Employees
1,434
Market Cap
4.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 924.53M | 236.74M | 34.42% |
| Dec 31, 2024 | 687.79M | -379.43M | -35.55% |
| Dec 31, 2023 | 1.07B | 180.64M | 20.38% |
| Dec 31, 2022 | 886.57M | 128.41M | 16.94% |
| Jan 1, 2022 | 758.16M | 125.47M | 19.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.